T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$3.11B |
| 2 |
Meta Platforms (Facebook)
META
|
+$2.59B |
| 3 |
EQT Corp
EQT
|
+$1.31B |
| 4 |
Colgate-Palmolive
CL
|
+$1.08B |
| 5 |
Adobe
ADBE
|
+$1.06B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.92B |
| 2 |
UnitedHealth
UNH
|
+$1.78B |
| 3 |
Advanced Micro Devices
AMD
|
+$1.55B |
| 4 |
Ross Stores
ROST
|
+$1.54B |
| 5 |
ASML
ASML
|
+$1.49B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.61% |
| 2 | Healthcare | 16.91% |
| 3 | Consumer Discretionary | 11.05% |
| 4 | Financials | 10.6% |
| 5 | Communication Services | 9.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ETRN
1026
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $13.5M | ﹤0.01% |
1,407,239
-11,907,479
| -89% | -$79.9M |
|
1027
Patrick Industries
PATK
$2.79B
| $13.4M | ﹤0.01% |
252,102
+81,274
| +48% | +$3.83M |
|
|
AZPN
1028
DELISTED
Aspen Technology Inc
AZPN
| $13.4M | ﹤0.01% |
80,048
-75,327
| -48% | -$14M |
|
1029
Eastman Chemical
EMN
$8.29B
| $13.3M | ﹤0.01% |
158,353
-713,735
| -82% | -$58M |
|
1030
Crown Holdings
CCK
$13.1B
| $13.1M | ﹤0.01% |
150,891
-327,910
| -68% | -$27M |
|
1031
iShares Russell 1000 Growth ETF
IWF
$129B
| $12.9M | ﹤0.01% |
188,088
+38,372
| +26% | +$2.44M |
|
1032
Madrigal Pharmaceuticals
MDGL
$12.4B
| $12.8M | ﹤0.01% |
55,403
+8,403
| +18% | +$2.28M |
|
1033
Norwegian Cruise Line
NCLH
$8.98B
| $12.5M | ﹤0.01% |
572,721
+7,059
| +1% | +$108K |
|
|
SKX
1034
DELISTED
Skechers
SKX
| $12.4M | ﹤0.01% |
236,126
+1,256
| +0.5% | +$64.3K |
|
|
LBPH
1035
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
| $12.4M | ﹤0.01% |
1,691,330
+226,556
| +15% | +$1.72M |
|
1036
Campbell Soup
CPB
$6.94B
| $12.4M | ﹤0.01% |
271,309
-2,263
| -0.8% | -$117K |
|
1037
Badger Meter
BMI
$3.91B
| $12.4M | ﹤0.01% |
83,860
-234
| -0.3% | -$32.2K |
|
1038
Voya Financial
VOYA
$9.01B
| $12.3M | ﹤0.01% |
171,583
-41,604
| -20% | -$2.99M |
|
1039
Fox Class A
FOXA
$27.5B
| $12.3M | ﹤0.01% |
361,377
-36,624
| -9% | -$1.2M |
|
1040
Robert Half
RHI
$4.25B
| $12.2M | ﹤0.01% |
162,368
-932
| -0.6% | -$66.5K |
|
1041
Mueller Water Products
MWA
$4.09B
| $12.2M | ﹤0.01% |
748,819
+48,197
| +7% | +$686K |
|
1042
BWX Technologies
BWXT
$15.8B
| $12.1M | ﹤0.01% |
169,662
-10,723
| -6% | -$701K |
|
1043
Maravai LifeSciences
MRVI
$861M
| $12.1M | ﹤0.01% |
975,770
+1,030
| +0.1% | +$13.9K |
|
1044
Generac Holdings
GNRC
$13.1B
| $12.1M | ﹤0.01% |
81,143
-937
| -1% | -$107K |
|
|
BWIN
1045
Baldwin Insurance Group
BWIN
$3B
| $12M | ﹤0.01% |
485,370
+504
| +0.1% | +$11.9K |
|
1046
RB Global
RBA
$16B
| $12M | ﹤0.01% |
200,097
-58,142
| -23% | -$3.28M |
|
1047
Alpha Metallurgical Resources
AMR
$2.02B
| $11.9M | ﹤0.01% |
72,635
+21,165
| +41% | +$3.24M |
|
1048
Twist Bioscience
TWST
$7.85B
| $11.9M | ﹤0.01% |
581,640
+180,411
| +45% | +$2.7M |
|
|
ARNC
1049
DELISTED
Arconic Corporation
ARNC
| $11.7M | ﹤0.01% |
396,313
-18,626
| -4% | -$514K |
|
|
THRX
1050
DELISTED
Theseus Pharmaceuticals, Inc. Common Stock
THRX
| $11.7M | ﹤0.01% |
1,256,009
-69,556
| -5% | -$685K |
|
Similar funds
T. Rowe Price Associates's Q2 2023 Portfolio in Review
As of Q2 2023, T. Rowe Price Associates held 3,044 positions worth $718B, up 7.4% from $668B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
T. Rowe Price Associates's Q2 2023 filing shows 123 new, 1,636 increased, 968 reduced and 150 closed positions. Its largest new stake was Kenvue: 26,317,608 shares worth $695M. The largest sale was Microsoft, an estimated $1.92B.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 30% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2023 buy was Kenvue: 26,317,608 shares worth $695M.
- T. Rowe Price Associates added most to Amazon in Q2 2023, an estimated $3.11B increase.
- T. Rowe Price Associates's biggest Q2 2023 reduction was Microsoft, cutting an estimated $1.92B.
- T. Rowe Price Associates fully exited Canadian Natural Resources in Q2 2023, selling an estimated $112M.
- T. Rowe Price Associates's ten largest holdings make up 32% of its $718B portfolio in Q2 2023.
- T. Rowe Price Associates opened 123 new positions and closed 150 in Q2 2023.
- T. Rowe Price Associates's portfolio value rose 7.4% quarter-over-quarter to $718B.
Based on T. Rowe Price Associates's 13F filing for Q2 2023, filed 14 Aug 2023.